Canada· CA-DIN-02265427
BENYLIN EXTRA STRENGTH CHEST CONGESTION & COLD
A guaifenesin product containing guaifenesin + menthol, registered in Canada by MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC. The same ATC class is registered in 14 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Guaifenesin is registered in 14 of 19 countries.
Countries holding a registration under ATC R05CA03 (guaifenesin), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 9 of them publish a price we can compare per daily dose
Guaifenesin · ATC R05CA03
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of guaifenesin costs, country by country.
Normalised to the WHO defined daily dose (0.9 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Guaifenesin · price per daily dose (0.9 g)
USD · FX 28 Sept 2026
- US United States$0.29 (acquisition cost)
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- GUAIFENESIN + MENTHOL
- Manufacturer
- MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
- Country
- Canada (CA)
- ATC code
- R05CA03
- ATC class
- Guaifenesin
- Defined daily dose
- 0.9 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Guaifenesin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c59c4884-96fa-4559-b1f0-d89d76f5e56d GET /v1/drugs/c59c4884-96fa-4559-b1f0-d89d76f5e56d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02265427",
"form": "SYRUP",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "R05CA03",
"schedule": [
"OTC"
],
"drug_code": "75089",
"strengths": [
"200 MG",
"15 MG"
],
"ahfs_class": null,
"substances": [
"GUAIFENESIN",
"MENTHOL"
],
"product_categorization": null
}See everything about guaifenesin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.